Glassman Wealth Services’s Aratana Therapeutics, Inc. PETX Stock Holding History

Glassman Wealth Services’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-246	Closed	-$1K	–	1565
2019 Q2	$1K	Buy	+246	New	+$1.11K	﹤0.01%	1020

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Glassman Wealth Services's PETX Position: Q3 2019 in Review

Glassman Wealth Services sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 246 shares — an estimated $1K sold.

Glassman Wealth Services first reported a position in PETX in Q2 2019 and held it in 1 quarter. The position peaked at $1K in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Glassman Wealth Services reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Glassman Wealth Services sold 246 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $1K.
Glassman Wealth Services first reported a position in Aratana Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
Glassman Wealth Services's Aratana Therapeutics, Inc. position peaked at $1K in Q2 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Glassman Wealth Services's 13F filing for Q3 2019, filed 1 Nov 2019.